Back to Nad research
nad 2026-01-01 PubMed

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities.


Abstract

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities. Authors: Ma Z, Gong X, Liu F Journal: Frontiers in oncology (2026) DOI: 10.3389/fonc.20…

nad
Source: pubmed:42294340 · Ingested 2026-06-19 · Digest: claude-sonnet-4-6